Fig. 6From: Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitorsSuggested chemically feasible optimized derivatives 8a-u from the selected promising scaffold 8aBack to article page